A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/17894791

Download in:

View as

General Info

PMID
17894791